Logo image of FTK

FLOTEK INDUSTRIES INC (FTK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:FTK - US3433894090 - Common Stock

16.38 USD
+0.37 (+2.31%)
Last: 12/5/2025, 8:23:30 PM
16.38 USD
0 (0%)
After Hours: 12/5/2025, 8:23:30 PM
Fundamental Rating

5

FTK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. FTK has an average financial health and profitability rating. FTK is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year FTK was profitable.
FTK had a negative operating cash flow in the past year.
In multiple years FTK reported negative net income over the last 5 years.
FTK had negative operating cash flow in 4 of the past 5 years.
FTK Yearly Net Income VS EBIT VS OCF VS FCFFTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

FTK has a better Return On Assets (15.01%) than 100.00% of its industry peers.
The Return On Equity of FTK (28.90%) is better than 97.56% of its industry peers.
The Return On Invested Capital of FTK (12.92%) is better than 90.24% of its industry peers.
Industry RankSector Rank
ROA 15.01%
ROE 28.9%
ROIC 12.92%
ROA(3y)-1.28%
ROA(5y)-44.59%
ROE(3y)-531.16%
ROE(5y)-406.73%
ROIC(3y)N/A
ROIC(5y)N/A
FTK Yearly ROA, ROE, ROICFTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

FTK has a Profit Margin of 14.48%. This is amongst the best in the industry. FTK outperforms 93.90% of its industry peers.
Looking at the Operating Margin, with a value of 12.08%, FTK is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
FTK has a Gross Margin (25.81%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FTK has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 14.48%
GM 25.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.33%
GM growth 5YN/A
FTK Yearly Profit, Operating, Gross MarginsFTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FTK is still creating some value.
FTK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FTK has more shares outstanding
Compared to 1 year ago, FTK has an improved debt to assets ratio.
FTK Yearly Shares OutstandingFTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
FTK Yearly Total Debt VS Total AssetsFTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

FTK has an Altman-Z score of 2.69. This is not the best score and indicates that FTK is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.69, FTK is in the better half of the industry, outperforming 79.27% of the companies in the same industry.
FTK has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
FTK's Debt to Equity ratio of 0.42 is fine compared to the rest of the industry. FTK outperforms 70.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 2.69
ROIC/WACC1.47
WACC8.8%
FTK Yearly LT Debt VS Equity VS FCFFTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

FTK has a Current Ratio of 1.77. This is a normal value and indicates that FTK is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.77, FTK perfoms like the industry average, outperforming 43.90% of the companies in the same industry.
FTK has a Quick Ratio of 1.54. This is a normal value and indicates that FTK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.54, FTK is in the better half of the industry, outperforming 64.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.54
FTK Yearly Current Assets VS Current LiabilitesFTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 288.46% over the past year.
Looking at the last year, FTK shows a very strong growth in Revenue. The Revenue has grown by 23.56%.
Measured over the past years, FTK shows a quite strong growth in Revenue. The Revenue has been growing by 9.39% on average per year.
EPS 1Y (TTM)288.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%575%
Revenue 1Y (TTM)23.56%
Revenue growth 3Y62.86%
Revenue growth 5Y9.39%
Sales Q2Q%12.64%

3.2 Future

The Earnings Per Share is expected to grow by 67.47% on average over the next years. This is a very strong growth
FTK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.05% yearly.
EPS Next Y210.28%
EPS Next 2Y76.84%
EPS Next 3Y67.47%
EPS Next 5YN/A
Revenue Next Year20.44%
Revenue Next 2Y16.45%
Revenue Next 3Y17.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FTK Yearly Revenue VS EstimatesFTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
FTK Yearly EPS VS EstimatesFTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

4

4. Valuation

4.1 Price/Earnings Ratio

FTK is valuated correctly with a Price/Earnings ratio of 16.22.
Based on the Price/Earnings ratio, FTK is valued a bit cheaper than 60.98% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.49, FTK is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.87, which indicates a correct valuation of FTK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FTK is on the same level as its industry peers.
FTK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.22
Fwd PE 15.87
FTK Price Earnings VS Forward Price EarningsFTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FTK is valued a bit more expensive than the industry average as 73.17% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.8
FTK Per share dataFTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

FTK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FTK's earnings are expected to grow with 67.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y76.84%
EPS Next 3Y67.47%

0

5. Dividend

5.1 Amount

FTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FLOTEK INDUSTRIES INC

NYSE:FTK (12/5/2025, 8:23:30 PM)

After market: 16.38 0 (0%)

16.38

+0.37 (+2.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners38.11%
Inst Owner Change9.05%
Ins Owners2.99%
Ins Owner Change0.01%
Market Cap492.38M
Revenue(TTM)220.50M
Net Income(TTM)31.93M
Analysts80
Price Target20.92 (27.72%)
Short Float %19.4%
Short Ratio6.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)110.69%
Min EPS beat(2)11.25%
Max EPS beat(2)210.12%
EPS beat(4)4
Avg EPS beat(4)74.56%
Min EPS beat(4)11.25%
Max EPS beat(4)210.12%
EPS beat(8)5
Avg EPS beat(8)34.34%
EPS beat(12)7
Avg EPS beat(12)-24.09%
EPS beat(16)8
Avg EPS beat(16)-46.78%
Revenue beat(2)2
Avg Revenue beat(2)6.27%
Min Revenue beat(2)3.6%
Max Revenue beat(2)8.95%
Revenue beat(4)4
Avg Revenue beat(4)10.37%
Min Revenue beat(4)3.05%
Max Revenue beat(4)25.86%
Revenue beat(8)5
Avg Revenue beat(8)2.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.47%
PT rev (3m)16.53%
EPS NQ rev (1m)-8.37%
EPS NQ rev (3m)-1.1%
EPS NY rev (1m)50.42%
EPS NY rev (3m)52.68%
Revenue NQ rev (1m)-1.22%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 16.22
Fwd PE 15.87
P/S 2.23
P/FCF N/A
P/OCF N/A
P/B 4.46
P/tB 4.46
EV/EBITDA 18.8
EPS(TTM)1.01
EY6.17%
EPS(NY)1.03
Fwd EY6.3%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS7.34
BVpS3.68
TBVpS3.68
PEG (NY)0.08
PEG (5Y)N/A
Graham Number9.14
Profitability
Industry RankSector Rank
ROA 15.01%
ROE 28.9%
ROCE 17.06%
ROIC 12.92%
ROICexc 13.3%
ROICexgc 13.3%
OM 12.08%
PM (TTM) 14.48%
GM 25.81%
FCFM N/A
ROA(3y)-1.28%
ROA(5y)-44.59%
ROE(3y)-531.16%
ROE(5y)-406.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.33%
GM growth 5YN/A
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 1.66
Cap/Depr 219.08%
Cap/Sales 1.43%
Interest Coverage 10.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.54
Altman-Z 2.69
F-Score3
WACC8.8%
ROIC/WACC1.47
Cap/Depr(3y)140.85%
Cap/Depr(5y)93.69%
Cap/Sales(3y)0.64%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)288.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%575%
EPS Next Y210.28%
EPS Next 2Y76.84%
EPS Next 3Y67.47%
EPS Next 5YN/A
Revenue 1Y (TTM)23.56%
Revenue growth 3Y62.86%
Revenue growth 5Y9.39%
Sales Q2Q%12.64%
Revenue Next Year20.44%
Revenue Next 2Y16.45%
Revenue Next 3Y17.05%
Revenue Next 5YN/A
EBIT growth 1Y182.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.97%
EBIT Next 3Y90.41%
EBIT Next 5YN/A
FCF growth 1Y36.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.04%
OCF growth 3YN/A
OCF growth 5YN/A

FLOTEK INDUSTRIES INC / FTK FAQ

What is the ChartMill fundamental rating of FLOTEK INDUSTRIES INC (FTK) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FTK.


What is the valuation status of FLOTEK INDUSTRIES INC (FTK) stock?

ChartMill assigns a valuation rating of 4 / 10 to FLOTEK INDUSTRIES INC (FTK). This can be considered as Fairly Valued.


Can you provide the profitability details for FLOTEK INDUSTRIES INC?

FLOTEK INDUSTRIES INC (FTK) has a profitability rating of 5 / 10.


What is the valuation of FLOTEK INDUSTRIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FLOTEK INDUSTRIES INC (FTK) is 16.22 and the Price/Book (PB) ratio is 4.46.


What is the financial health of FLOTEK INDUSTRIES INC (FTK) stock?

The financial health rating of FLOTEK INDUSTRIES INC (FTK) is 4 / 10.